- Home
- CMND
as of 06-22-2026 4:00pm EST
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
| Founded: | 2017 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 2.6M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 2.5M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $0.07 - $4.66 | Next Earning Date: | 03-12-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
AI-Powered CMND Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Clearmind Medicine Inc. (CMND)
10% Owner
Avg Cost/Share
$3.31
Shares
22,139
Total Value
$73,191.53
Owned After
81,353
SEC Form 4
10% Owner
Avg Cost/Share
$3.32
Shares
3,183
Total Value
$10,567.56
Owned After
81,353
SEC Form 4
10% Owner
Avg Cost/Share
$3.36
Shares
2,102
Total Value
$7,062.72
Owned After
81,353
SEC Form 4
10% Owner
Avg Cost/Share
$0.12
Shares
225,191
Total Value
$27,698.49
Owned After
81,353
SEC Form 4
10% Owner
Avg Cost/Share
$0.15
Shares
2,159,052
Total Value
$330,334.96
Owned After
2,063,266
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | CMND | 10% Owner | Jun 16, 2026 | Sell | $3.31 | 22,139 | $73,191.53 | 81,353 | |
| HRT FINANCIAL LP | CMND | 10% Owner | Jun 15, 2026 | Sell | $3.32 | 3,183 | $10,567.56 | 81,353 | |
| HRT FINANCIAL LP | CMND | 10% Owner | Jun 12, 2026 | Sell | $3.36 | 2,102 | $7,062.72 | 81,353 | |
| HRT FINANCIAL LP | CMND | 10% Owner | Jun 11, 2026 | Sell | $0.12 | 225,191 | $27,698.49 | 81,353 | |
| HRT FINANCIAL LP | CMND | 10% Owner | Jun 10, 2026 | Buy | $0.15 | 2,159,052 | $330,334.96 | 2,063,266 |
Compare CMND vs Leading Stocks
See how CMND stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CMND Clearmind Medicine Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.